Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proteases”

671 trials

Showing 20 of 671 results

Not applicableUnknownNCT04750161
What this trial is testing

The Role Of Neutrophil Proteases As Global Regulators Of Il-1 Family Cytokine Activity In Skin Disorders

Who this might be right for
Psoriasis VulgarisAtopic DermatitisIchthyosis Vulgaris
St. James's Hospital, Ireland 80
Not applicableStudy completedNCT01379703
What this trial is testing

Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use

Who this might be right for
HIV-1 Patients
Abbott 2,288
Not applicableStudy completedNCT00000895
What this trial is testing

Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Testing effectiveness (Phase 2)Study completedNCT00027339
What this trial is testing

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 53
Early research (Phase 1)Study completedNCT00357604
What this trial is testing

Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females

Who this might be right for
HIV Infections
Bristol-Myers Squibb 22
Not applicableStudy completedNCT00000922
What this trial is testing

Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,710
Early research (Phase 1)Study completedNCT00002111
What this trial is testing

A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.

Who this might be right for
HIV Infections
Stanford University 32
Not applicableStudy completedNCT02926456
What this trial is testing

Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)

Who this might be right for
Human Immunodeficiency Virus
Janssen-Cilag S.p.A. 337
Large-scale testing (Phase 3)Study completedNCT00002245
What this trial is testing

The Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Ended earlyNCT04171219
What this trial is testing

Talabostat and Pembrolizumab for the Treatment of Advanced Solid Cancers

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm
M.D. Anderson Cancer Center 31
Early research (Phase 1)Study completedNCT00307502
What this trial is testing

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 675
Not applicableStudy completedNCT00014937
What this trial is testing

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Early research (Phase 1)Study completedNCT00002372
What this trial is testing

141W94 in Combination With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 48
Not applicableStudy completedNCT06503081
What this trial is testing

Crohn's Disease - Inflammation and Microbial Proteolytic Activity

Who this might be right for
Crohn's Disease of Both Small and Large Intestine
McMaster University 30
Large-scale testing (Phase 3)Study completedNCT02525861
What this trial is testing

GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study

Who this might be right for
Alpha1-antitrypsin Deficiency
Baxalta now part of Shire 34
Not applicableStudy completedNCT00859391
What this trial is testing

Effects of Gluten Digestion With ALV003

Who this might be right for
Celiac Disease
Alvine Pharmaceuticals Inc. 20
Large-scale testing (Phase 3)Looking for participantsNCT06679140
What this trial is testing

Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Who this might be right for
COVID-19 SARS-CoV-2 Infection
Pfizer 2,330
Large-scale testing (Phase 3)Study completedNCT00043888
What this trial is testing

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Who this might be right for
HIV Infections
GlaxoSmithKline 60
Early research (Phase 1)Study completedNCT06263270
What this trial is testing

Evaluation of CYT-108, A Recombinant Protease Inhibitor, for Treatment of Mild To Moderate Primary Osteoarthritis Of The Knee

Who this might be right for
Osteoarthritis, KneeOsteoarthritis
Cytonics Corporation 19
Testing effectiveness (Phase 2)Study completedNCT02207439
What this trial is testing

Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Abramson Cancer Center at Penn Medicine 18
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation